| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
Revenue  | 18 | 17 | 27 | 22 | 21 | 24 | 25 | 19 | 18 | 24 | 34 | 26 | 36 | 29 | 32 | 27 | 24 | 20 | 30 | 29 | 30 | 35 | 31 | 28 | 27 | 27 | 32 | 35 | 42 | 31 | 29 | 30 |
| Expenses | 16 | 16 | 23 | 22 | 19 | 23 | 22 | 19 | 15 | 21 | 30 | 24 | 29 | 23 | 26 | 24 | 21 | 19 | 25 | 20 | 27 | 29 | 25 | 20 | 21 | 21 | 22 | 25 | 40 | 19 | 29 | 28 |
| EBITDA | 2 | 1 | 3 | -1 | 2 | 1 | 3 | -0 | 4 | 3 | 4 | 2 | 7 | 6 | 6 | 3 | 3 | 1 | 5 | 9 | 3 | 6 | 6 | 8 | 6 | 6 | 10 | 10 | 3 | 12 | 1 | 2 |
| Operating Profit % | 7 % | 0 % | 11 % | -15 % | 7 % | 4 % | 9 % | -7 % | 11 % | 8 % | 9 % | 5 % | 8 % | 13 % | 13 % | 4 % | 7 % | -42 % | 10 % | 32 % | -4 % | 10 % | 9 % | 15 % | 2 % | 2 % | 13 % | 3 % | 1 % | 2 % | -9 % | 5 % |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 0 | 2 | -1 | 1 | 0 | 3 | -1 | 3 | 2 | 4 | 2 | 7 | 6 | 5 | 2 | 3 | 0 | 5 | 8 | 3 | 6 | 5 | 7 | 5 | 5 | 10 | 9 | 2 | 12 | 0 | 2 |
| Tax | -0 | 0 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 3 | 0 | 0 | 1 | 3 | 0 | 0 | 2 | 0 | 4 | 0 | 0 | -0 |
| Net Profit | 2 | 0 | 2 | -3 | 1 | 0 | 3 | -2 | 3 | 2 | 4 | -2 | 7 | 6 | 5 | -4 | 3 | 0 | 5 | 5 | 3 | 6 | 5 | 4 | 5 | 5 | 8 | 9 | -2 | 12 | 0 | 2 |
| EPS in ₹ | 0.76 | 0.09 | 1.13 | -1.46 | 0.58 | 0.19 | 1.23 | -1.10 | 1.53 | 1.11 | 1.77 | -0.95 | 3.06 | 2.72 | 2.57 | -1.70 | 1.29 | 0.10 | 2.43 | 2.12 | 1.44 | 2.75 | 2.17 | 1.71 | 2.42 | 2.42 | 3.66 | 4.23 | -0.95 | 5.59 | 0.05 | 0.90 |
Alpa Laboratories
Alpa Laboratories
68.48
-0.96
(-1.38%)
Market Cap
144.09 Cr
PE Ratio
12.62
Volume
11,328.00
Day High - Low
69.46 - 68.20
52W High-Low
120.50 - 46.10
Key Fundamentals
Market Cap
144.09 Cr
EPS
9.34
PE Ratio
12.62
PB Ratio
0.80
Book Value
87.12
EBITDA
28.10
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
11.38
Debt to Equity
0.02
Actual
Company News
View All News
Alpa Labs Appoints New Company Secretary & CO
Apr 11, 2026
Apr 11, 2026Alpa Laboratories Ltd. announces the appointment of Ms. Yashoda Patidar as Company Secretary and Compliance Officer effective April 11, 2026, following board approval based on committee recommendations.
Alpa Labs clarifies no price sensitive infoApr 10, 2026
Apr 10, 2026Alpa Laboratories responds to stock exchange inquiry about price movement, confirms no undisclosed material information or upcoming announcements affecting stock performance.
Alpa Laboratories reports inter se transfer of 21,940 shares (0.10%) from Bakulesh Chandulal Shah HUF to Vinit Shah as gift between immediate relatives on March 7, 2026.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,620.40 | #1 3,88,788.24 | 36.80 | #1 54,729.00 | 9.71 | #1 10,980 | 16.07 | 33.27 | |
6,361.50 | 1,68,877.84 | 68.31 | 9,712.00 | 18.67 | 2,191 | -1.02 | 63.24 | |
4,117.20 | 1,39,344.76 | 61.76 | 11,539.40 | 6.99 | 1,911 | 26.24 | 45.65 | |
1,317.10 | 1,09,930.83 | 20.15 | 33,741.20 | 16.73 | 5,725 | -15.28 | 61.94 | |
2,296.10 | 1,04,941.69 | 22.91 | 22,909.50 | 13.74 | 3,306 | #1 37.44 | 47.90 | |
1,295.00 | 1,04,607.60 | 23.27 | 28,409.50 | 7.12 | 5,291 | -57.18 | 60.61 | |
2,267.40 | 93,599.42 | 52.47 | 12,744.20 | #1 20.90 | 2,007 | 7.65 | 67.86 | |
927.40 | 93,318.14 | #1 18.96 | 23,511.00 | 18.55 | 4,615 | -0.32 | 55.15 | |
1,413.80 | 82,113.73 | 23.93 | 32,345.60 | 9.43 | 3,484 | 7.59 | 66.95 | |
2,299.50 | 64,892.08 | 61.93 | 13,435.50 | 6.18 | 1,047 | 15.86 | 63.32 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
9.87 %
Net Income Growth
16.07 %
Cash Flow Change
401.92 %
ROE
3.08 %
ROCE
7.92 %
EBITDA Margin (Avg.)
11.24 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 128 | 144 | 126 | 122 | 121 | 121 | 140 | 155 | 167 | 182 | 223 |
| Fixed Assets | 5 | 15 | 15 | 10 | 8 | 6 | 7 | 9 | 7 | 12 | 21 |
| Current Assets | 113 | 117 | 105 | 98 | 94 | 96 | 121 | 138 | 149 | 161 | 193 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 13 | 31 | 49 | 57 | 51 | 75 | 79 | 98 | 118 |
| Other Assets | 123 | 130 | 97 | 81 | 65 | 58 | 81 | 71 | 82 | 73 | 84 |
| Total Equity & Liabilities | 128 | 144 | 126 | 122 | 121 | 121 | 140 | 155 | 167 | 182 | 223 |
| Current Liabilities | 41 | 50 | 30 | 23 | 22 | 21 | 33 | 31 | 30 | 28 | 47 |
| Non Current Liabilities | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 2 | 3 | 2 | 5 |
| Total Equity | 87 | 93 | 95 | 98 | 99 | 100 | 108 | 122 | 135 | 152 | 171 |
| Reserve & Surplus | 66 | 72 | 74 | 77 | 78 | 79 | 87 | 101 | 114 | 131 | 150 |
| Share Capital | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 42 | -36 | 0 | -15 | -20 | 5 | 4 | -0 | 7 | -7 | 1 |
| Investing Activities | 37 | -8 | -2 | -12 | -15 | -11 | 6 | -16 | 2 | -13 | -12 |
| Operating Activities | -2 | -22 | 17 | -13 | -1 | 18 | -2 | 10 | 9 | 4 | 18 |
| Financing Activities | 7 | -6 | -15 | 9 | -5 | -1 | 0 | 5 | -4 | 3 | -5 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 56.66 % | 56.66 % | 56.66 % | 56.66 % | 57.29 % | 57.29 % | 57.29 % | 57.29 % | 57.29 % | 57.29 % | 57.29 % | 57.29 % | 57.29 % | 57.29 % | 57.29 % | 57.29 % | 57.29 % | 57.29 % | 57.29 % | 57.29 % | 57.19 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.11 % | 0.00 % | 0.50 % | 0.36 % | 0.74 % | 0.35 % | 0.40 % | 0.36 % | 0.35 % | 0.36 % | 0.38 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.05 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 38.54 % | 38.09 % | 38.34 % | 36.39 % | 37.18 % | 37.92 % | 37.72 % | 37.88 % | 38.10 % | 37.78 % | 37.61 % | 36.84 % | 36.83 % | 36.65 % | 36.09 % | 36.80 % | 37.32 % | 37.28 % | 37.14 % | 36.78 % | 36.75 % |
| Others | 4.80 % | 5.24 % | 5.00 % | 6.90 % | 5.53 % | 4.78 % | 4.99 % | 4.82 % | 4.59 % | 4.91 % | 4.99 % | 5.86 % | 5.37 % | 5.70 % | 5.87 % | 5.55 % | 4.99 % | 5.06 % | 5.21 % | 5.57 % | 5.68 % |
| No of Share Holders | 13,240 | 15,547 | 15,595 | 16,114 | 18,775 | 18,796 | 18,840 | 19,094 | 19,137 | 18,745 | 18,565 | 18,682 | 18,690 | 18,116 | 18,885 | 19,206 | 18,872 | 18,851 | 18,542 | 18,236 | 17,900 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 29 Sept 2023 |  Annual General Meeting | NA | 29 Sept 2023 | 79.35 | 72.01 |
| 28 Sept 2024 | Annual General Meeting | NA | 28 Sept 2024 | 118.90 | 131.85 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 113.90 | 112.00 |
| 13 Feb 2025 | Quarterly Result Announcement | NA | 13 Feb 2025 | 116.55 | 101.90 |
| 28 May 2025 | Quarterly Result Announcement | NA | 28 May 2025 | 108.15 | 112.50 |
| 13 Aug 2025 | Quarterly Result Announcement | NA | 13 Aug 2025 | 101.30 | 95.75 |
| 29 Sept 2025 | Annual General Meeting | NA | 29 Sept 2025 | 95.12 | 90.97 |
| 14 Nov 2025 | Quarterly Result Announcement | NA | 14 Nov 2025 | 90.62 | 85.60 |
| 11 Feb 2026 | Quarterly Result Announcement | NA | 11 Feb 2026 | 63.60 | 74.80 |
Announcements
Appointment of Company Secretary and Compliance OfficerApr 11, 2026
Apr 11, 2026ClarificationApr 09, 2026
Apr 09, 2026Clarification Sought from Alpa Laboratories LtdApr 08, 2026
Apr 08, 2026Closure of Trading WindowMar 20, 2026
Mar 20, 2026Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011Mar 09, 2026
Mar 09, 2026Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011Mar 09, 2026
Mar 09, 2026Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerFeb 25, 2026
Feb 25, 2026Alpa Laboratories Limited Has Submitted To The Exchange The Financial Results For The Period Ended December 31 2025.Feb 11, 2026
Feb 11, 2026Board Meeting Outcome for Financial ResultsFeb 11, 2026
Feb 11, 2026Board Meeting Intimation for Consider And Approve The Financial Results For The Period Ended December 31 2025Jan 29, 2026
Jan 29, 2026Financial Results For The Quarter And Half Year Ended September 302025Nov 14, 2025
Nov 14, 2025Board Meeting Intimation for Board Meeting IntimationNov 04, 2025
Nov 04, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2025
Oct 01, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 27, 2025
Sep 27, 2025Book Closure For The Purpose Of Annual General Meeting.Sep 05, 2025
Sep 05, 2025Reg. 34 (1) Annual Report.Sep 04, 2025
Sep 04, 2025Board Meeting Outcome for Alpa Laboratories Limited Has Submitted To The Exchange The Financial Results For The Period Ended Jun 30 2025.Aug 13, 2025
Aug 13, 2025Board Meeting Intimation for To Consider And Approve The Financial Results For The Period Ended Jun 30 2025 And Other Business Matters.Aug 01, 2025
Aug 01, 2025Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011Jul 05, 2025
Jul 05, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceJun 27, 2025
Jun 27, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 27, 2025
Jun 27, 2025Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011Jun 27, 2025
Jun 27, 2025Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011Jun 27, 2025
Jun 27, 2025Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011Jun 20, 2025
Jun 20, 2025Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011Jun 20, 2025
Jun 20, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 20, 2025
Jun 20, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 18, 2025
Jun 18, 2025Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011Jun 18, 2025
Jun 18, 2025Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011Jun 18, 2025
Jun 18, 2025Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011Jun 09, 2025
Jun 09, 2025Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011Jun 09, 2025
Jun 09, 2025Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011Jun 09, 2025
Jun 09, 2025Board Meeting Outcome for Alpa Laboratories Limited Has Submitted To The Exchange The Financial Results For The Period Ended March 31 2025.May 28, 2025
May 28, 2025Board Meeting Intimation for To Consider And Approve The Financial Results For The Period Ended March 31 2025May 17, 2025
May 17, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Clarification On The Format Prescribed By SEBI For The Financial Results.Mar 18, 2025
Mar 18, 2025Integrated Filing (Financial)Feb 17, 2025
Feb 17, 2025Change In Designation Of Mr. Vitthal Kothana (DIN- 09489318) From Non-Executive Director To Executive Director.Feb 14, 2025
Feb 14, 2025Appointment of Company Secretary and Compliance OfficerFeb 13, 2025
Feb 13, 2025Financial Results For The Quarter Ended December 2024Feb 13, 2025
Feb 13, 2025Announcement under Regulation 30 (LODR)-AcquisitionFeb 07, 2025
Feb 07, 2025Board Meeting Intimation for To Approve The Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 31St December 2024.
Feb 03, 2025
Feb 03, 2025Closure of Trading WindowDec 30, 2024
Dec 30, 2024Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerNov 14, 2024
Nov 14, 2024Board Meeting Outcome for Financial Results For The Quarter And Half Year Ended 30Th September,2024Nov 14, 2024
Nov 14, 2024Financial Results For The Quarter And Half Year Ended 30Th September,2024Nov 14, 2024
Nov 14, 2024Board Meeting Intimation for Quarter And Half Year Ended September,2024Nov 06, 2024
Nov 06, 2024Intimation Of Website MaintenanceOct 26, 2024
Oct 26, 2024Technical Indicators
RSI(14)
Neutral 59.45
ATR(14)
Less Volatile 3.58
STOCH(9,6)
Neutral 66.63
STOCH RSI(14)
Overbought 85.76
MACD(12,26)
Bullish 0.79
ADX(14)
Weak Trend 18.08
UO(9)
Bearish 54.22
ROC(12)
Uptrend And Accelerating 11.82
WillR(14)
Overbought -12.69
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
